These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


163 related items for PubMed ID: 34462911

  • 1. Antiseizure medication adherence trajectories in Medicare beneficiaries with newly treated epilepsy.
    Terman SW, Kerr WT, Marcum ZA, Wang L, Burke JF.
    Epilepsia; 2021 Nov; 62(11):2778-2789. PubMed ID: 34462911
    [Abstract] [Full Text] [Related]

  • 2. Incidence of and predictors for antiseizure medication gaps in Medicare beneficiaries with epilepsy: a retrospective cohort study.
    Terman SW, Niznik JD, Slinger G, Otte WM, Braun KPJ, Aubert CE, Kerr WT, Boyd CM, Burke JF.
    BMC Neurol; 2022 Sep 01; 22(1):328. PubMed ID: 36050646
    [Abstract] [Full Text] [Related]

  • 3. Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy.
    Terman SW, Youngerman BE, Choi H, Burke JF.
    Epilepsia; 2022 Jun 01; 63(6):1571-1579. PubMed ID: 35294775
    [Abstract] [Full Text] [Related]

  • 4. Adherence to Antiseizure vs Other Medications Among US Medicare Beneficiaries With and Without Epilepsy.
    Terman SW, Kerr WT, Aubert CE, Hill CE, Marcum ZA, Burke JF.
    Neurology; 2022 Jan 24; 98(4):e427-e436. PubMed ID: 34893556
    [Abstract] [Full Text] [Related]

  • 5. Adherence to antiseizure medications in an underserved population with epilepsy.
    Gonzalez A, Pandey D, Digiannantonio N, Serafini A.
    Epilepsy Behav; 2023 Dec 24; 149():109484. PubMed ID: 37988904
    [Abstract] [Full Text] [Related]

  • 6. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications.
    Axon DR, Vaffis S, Chinthammit C, Lott BE, Taylor AM, Pickering M, Black H, Warholak T, Campbell PJ.
    J Manag Care Spec Pharm; 2020 Dec 24; 26(12):1529-1537. PubMed ID: 33251989
    [Abstract] [Full Text] [Related]

  • 7. Predictors of adherence to direct oral anticoagulants after cardiovascular or bleeding events in Medicare Advantage Plan enrollees with atrial fibrillation.
    Fatima B, Mohan A, Altaie I, Abughosh S.
    J Manag Care Spec Pharm; 2024 May 24; 30(5):408-419. PubMed ID: 38701026
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Alignment of diagnosis and pharmacy claims data coding of medication adherence among patients with diabetes or hypertension.
    Gatwood J, Hohmeier KC, Shuvo S, Mikaiel D, Kovesdy CP.
    J Manag Care Spec Pharm; 2021 Apr 24; 27(4):497-506. PubMed ID: 33769854
    [Abstract] [Full Text] [Related]

  • 11. Changes in the Use of Brand Name and Generic Medications and Total Prescription Cost Among Medicare Beneficiaries With Epilepsy.
    Terman SW, Lin CC, Kerr WT, DeLott LB, Callaghan BC, Burke JF.
    Neurology; 2022 Aug 22; 99(8):e751-e761. PubMed ID: 35705496
    [Abstract] [Full Text] [Related]

  • 12. Economic impact of epilepsy and the cost of nonadherence to antiepileptic drugs in older Medicare beneficiaries.
    Ip Q, Malone DC, Chong J, Harris RB, Labiner DM.
    Epilepsy Behav; 2018 Mar 22; 80():208-214. PubMed ID: 29414554
    [Abstract] [Full Text] [Related]

  • 13. Medication use patterns and predictors of nonpersistence and nonadherence with oral 5-aminosalicylic acid therapy in patients with ulcerative colitis.
    Yen L, Wu J, Hodgkins PL, Cohen RD, Nichol MB.
    J Manag Care Pharm; 2012 Mar 22; 18(9):701-12. PubMed ID: 23206213
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
    Iyengar RN, Balagere DS, Henderson RR, LeFrancois AL, Rabbitt RM, Frazee SG.
    J Manag Care Spec Pharm; 2014 Aug 22; 20(8):851-61. PubMed ID: 25062079
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Predictors of Nonadherence to Topical Intraocular Pressure Reduction Medications Among Medicare Members: A Claims-Based Retrospective Cohort Study.
    Sheer R, Bunniran S, Uribe C, Fiscella RG, Patel VD, Chandwani HS.
    J Manag Care Spec Pharm; 2016 Jul 22; 22(7):808-817a. PubMed ID: 27348282
    [Abstract] [Full Text] [Related]

  • 18. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool.
    Mhatre SK, Serna O, Sansgiry S, Fleming ML, Essien EJ, Sansgiry SS.
    J Manag Care Spec Pharm; 2016 Nov 22; 22(11):1293-1301. PubMed ID: 27783546
    [Abstract] [Full Text] [Related]

  • 19. Azathioprine and Mycophenolate Mofetil Adherence Patterns and Predictors Among Medicaid Beneficiaries With Systemic Lupus Erythematosus.
    Feldman CH, Collins J, Zhang Z, Xu C, Subramanian SV, Kawachi I, Solomon DH, Costenbader KH.
    Arthritis Care Res (Hoboken); 2019 Nov 22; 71(11):1419-1424. PubMed ID: 30354025
    [Abstract] [Full Text] [Related]

  • 20. Association of first antiseizure medication with acute health care utilization in a cohort of adults with newly diagnosed epilepsy.
    Blank LJ, Agarwal P, Kwon CS, Boockvar K, Jetté N.
    Epilepsia; 2024 Sep 28. PubMed ID: 39340471
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.